News about genomics analysis tools including next generation sequencing, electrophoresis, PCR, and others
SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ:ILMN) today announced that its executives will be speaking at the following investor conferences and invited investors to participate via webcast. Evercore ISI HEALTHCONx Conference in Boston, MAWednesday, November 28, 2018 at 11:00 am Eastern Time Piper Jaffray Healthcare Conference in New York, NYThursday, November 29, 2018 at 10:30 am Eastern... Read more
First end-to-end workflow for multi-species screening and identification BASINGSTOKE, England, Nov. 12, 2018 /PRNewswire/ — Thermo Fisher Scientific announced the introduction of a new, complete next generation sequencing (NGS) workflow for multi-species screening and identification for food authenticity. This comes after Oxoid Ltd. (a part of Thermo Fisher Scientific) and SGS MOLECULAR, S.A. signed a global... Read more
Company creates U.S. subsidiary and adds Dr. Jeffrey Jeddeloh as VP of Business Development, Commercial Strategy, Dr. Stephen Macevicz as VP of IP and Dr. Christine Peponnet as VP of Technology Development. PARIS and CAMBRIDGE, Mass., Nov 8, 2018 – DNA Script, the global leader in the development of enzymatic DNA synthesis, today announced the creation... Read more
PDF Version SEATTLE, Nov. 08, 2018 (GLOBE NEWSWIRE) — NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced the launch of a new gene expression panel for the molecular characterization of CAR-T cells in research, development and manufacturing. The nCounter® CAR-T Characterization Panel was created in collaboration with eight leading centers... Read more
Germantown, Maryland, and Hilden, Germany, June 7, 2018 – QIAGEN today announced the launch of the QIAseq 16S/ITS Panels and UCP Multiplex PCR Kit with a new generation of reagents to enable the most accurate microbial community profiling from complex microbiome samples. The new QIAseq NGS panels as well as the UCP Multiplex kit create... Read more
5-NOV-2018 Company introduces enhanced Arima-HiC product offering to drive greater insights for chromatin conformation and genome assembly studies ARIMA GENOMICS, INC. SAN DIEGO– Arima Genomics, Inc., a biotechnology company empowering researchers to apply long-range genetic sequence and structure information towards the understanding of health, disease and species evolution, announced today the full commercial launch of... Read more
DNAe achieves major milestone in a novel clinical sequencing platform, successfully completing the first phase of its $51.9 million contract with US government’s BARDA London, UK and Carlsbad, CA, USA – 2 November 2018 – A rapid new diagnostic platform that harnesses the power of semiconductor DNA sequencing, promises to revolutionise the ability of physicians to... Read more
SAN DIEGO & MENLO PARK, Calif.–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) and Pacific Biosciences (NASDAQ:PACB) today announced they have signed an agreement for Illumina to acquire Pacific Biosciences at a price of $8.00 per Pacific Biosciences share in an all-cash transaction. This price represents a premium of 71% to Pacific Biosciences’ 30 trading day volume weighted... Read more
DUBLIN, Ireland, and CAMBRIDGE, UK, November 01, 2018 – ERS Genomics Limited and DefiniGEN Ltd announced today a license agreement to provide DefiniGEN with access to ERS Genomic’s CRISPR/Cas9 genome editing technology patents. DefiniGEN will combine their best-in-class iPSC (induced Pluripotent Stem Cell) differentiation platform with CRISPR/Cas9 technology to generate a range of innovative preclinical... Read more